Voyager Therapeutics (VYGR) Price to Book (2015 - 2026)

Voyager Therapeutics has disclosed Price to Book across 12 years of filings, most recently posting 1.39 for Q2 2026.

• In Q2 2026, Price to Book rose 96.56% year-over-year to 1.39; the TTM figure through Jun 2026 stood at 1.39 (up 96.56% YoY), while the FY2025 annual figure was 1.18, up 14.32% from the prior year.
• Price to Book came in at 1.39 for Q2 2026 at Voyager Therapeutics, up from 1.34 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 3.99 in Q4 2022 to a low of 0.68 in Q1 2025.
• Average Price to Book over 5 years is 1.85, with a median of 1.44 recorded in 2024.
• Year-over-year, Price to Book jumped 269.17% in 2022 and tumbled 60.59% in 2023.
• Over 5 years, Price to Book stood at 3.99 in 2022, then plunged by 60.59% to 1.57 in 2023, then sank by 34.18% to 1.04 in 2024, then rose by 14.32% to 1.18 in 2025, then climbed by 17.38% to 1.39 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 1.39 in Q2 2026, 1.34 in Q1 2026, and 1.18 in Q4 2025.